APA

Tribius S., Reemts E., Prosch C., Raguse M., Petersen C., Kruell A., Singer S. & Bergelt C. (20130507). Global quality of life during the acute toxicity phase of multimodality treatment for patients with head and neck cancer: can we identify patients most at risk of profound quality of life decline?. : Oral oncology.

Chicago

Tribius S, Reemts E, Prosch C, Raguse M, Petersen C, Kruell A, Singer S and Bergelt C. 20130507. Global quality of life during the acute toxicity phase of multimodality treatment for patients with head and neck cancer: can we identify patients most at risk of profound quality of life decline?. : Oral oncology.

Harvard

Tribius S., Reemts E., Prosch C., Raguse M., Petersen C., Kruell A., Singer S. and Bergelt C. (20130507). Global quality of life during the acute toxicity phase of multimodality treatment for patients with head and neck cancer: can we identify patients most at risk of profound quality of life decline?. : Oral oncology.

MLA

Tribius S, Reemts E, Prosch C, Raguse M, Petersen C, Kruell A, Singer S and Bergelt C. Global quality of life during the acute toxicity phase of multimodality treatment for patients with head and neck cancer: can we identify patients most at risk of profound quality of life decline?. : Oral oncology. 20130507.